Jiangsu Hengrui Medicine Co., Ltd.
600276
Pozycja w akcjach
#544
Jiangsu Hengrui Medicine Co., Ltd. is a global biopharmaceutical firm engaged... Jiangsu Hengrui Medicine Co., Ltd. is a global biopharmaceutical firm engaged in the full spectrum of pharmaceutical operations, from the initial discovery and development of medications to their manufacturing and worldwide distribution. The company is actively advancing a substantial pipeline of drug candidates, which includes Apatinib, Pyrotinib, Mecapegfilgrastim, SHR3680, SHR3162, SHR9549, SHR2554, SHR1459, SHR-1309, SHR-A1201, Camrelizumab, Famitinib, SHR-1316, SHR-1501, SHR-1603, SHR-1701, SHR-1702, and SHR-A1403. These prospective treatments are aimed at a diverse range of medical conditions, primarily focusing on oncology, metabolic disorders, pain management, and autoimmune diseases, among others. The enterprise was founded in 1970 and maintains its corporate headquarters in Lianyungang, China.
Cena akcji
$6.89
Kapitalizacja rynkowa
$43.94B
Zmiana (1 dzień)
-2.91%
Zmiana (1 rok)
-24.78%
Kraj
CN
Handel Jiangsu Hengrui Medicine Co., Ltd. (600276)
Kategoria
Healthcare
Wskaźnik P/S dla Jiangsu Hengrui Medicine Co., Ltd. (600276)
Wskaźnik P/S na dzień October 2026 TTM: 9.37
Według najnowszych raportów finansowych i ceny akcji Jiangsu Hengrui Medicine Co., Ltd., obecny wskaźnik P/S (TTM) wynosi 9.37. Na koniec 2024 wynosił 10.39.
Historia wskaźnika P/S dla Jiangsu Hengrui Medicine Co., Ltd. od 2001 do 2026
Wskaźnik P/S na koniec każdego roku
| Rok | Wskaźnik P/S | Zmień |
|---|---|---|
| 2026 (TTM) | 9.37 | -23.96% |
| 2025 | 12.32 | 18.54% |
| 2024 | 10.39 | -17.13% |
| 2023 | 12.54 | 8.76% |
| 2022 | 11.53 | -7.68% |
| 2021 | 12.49 | -41.32% |
| 2020 | 21.29 | 28.72% |
| 2019 | 16.54 | 47.69% |
| 2018 | 11.20 | -3.36% |
| 2017 | 11.59 | 44.55% |
| 2016 | 8.02 | -6.62% |
| 2015 | 8.58 | 63.97% |
| 2014 | 5.24 | -9.71% |
| 2013 | 5.80 | 21.57% |
| 2012 | 4.77 | -5.76% |
| 2011 | 5.06 | -38.70% |
| 2010 | 8.26 | 10.18% |
| 2009 | 7.49 | 29.72% |
| 2008 | 5.78 | -34.42% |
| 2007 | 8.81 | 78.87% |
| 2006 | 4.92 | 420.22% |
| 2005 | 0.95 | 14.31% |
| 2004 | 0.83 | -8.27% |
| 2003 | 0.90 | -28.02% |
| 2002 | 1.25 | -16.11% |
| 2001 | 1.50 | 0.00% |
Wskaźnik P/S dla podobnych firm lub konkurentów
| Firma | Wskaźnik P/S | Różnica wskaźnika P/S | Kraj |
|---|---|---|---|
| - | - |
DE
|
|
| - | - |
DE
|
|
| 2.19 | -76.66% |
JP
|
|
| - | - |
CH
|
|
| 7.06 | -24.66% |
IN
|
